Press Releases - 2023-12-11

Date	Title	Company
11-Dec-2023	ImmunoGen Presents Findings from Newly Diagnosed Acute Myeloid Leukemia Cohorts in Phase 1b/2 Study of Pivekimab Sunirine in Combination with Azacitidine and Venetoclax at ASH	ImmunoGen
11-Dec-2023	New therapeutic target for rare type of childhood epilepsy	Francis Crick Institute
11-Dec-2023	Scottish Medicines Consortium accepts Sotyktu™▼ (deucravacitinib) for NHS use in certain adults with moderate to severe plaque psoriasis	Bristol Myers Squibb
11-Dec-2023	Shape Memory Medical Announces Sublicense of Intellectual Property	Businesswire
11-Dec-2023	Thermo Fisher Scientific Introduces New Sample Preparation Solutions to Simplify and Automate Respiratory Diagnostic Testing	Businesswire
11-Dec-2023	Alzamend Neuro Receives FDA “Study May Proceed” Notification for a Phase IIA Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, in Post-Traumatic Stress Disorder Patients	Businesswire
11-Dec-2023	Takara Bio USA Wins EU Opposition Hearing, Revoking Jumpcode Genomics’ NGS Library Enrichment Patent	Businesswire
11-Dec-2023	Synchron Appoints Andy Rasdal to Board of Directors	Businesswire
11-Dec-2023	United States Syringes & Needles Market Insights Report 2023: A $10.87 Billion Market by 2028 with BD, ICU Medical, Nipro Medical, Terumo, and Cardinal Health Emerging as Prominent Players - ResearchAndMarkets.com	Businesswire
11-Dec-2023	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
11-Dec-2023	New Report From Quest Diagnostics Unveils Priorities for Community Health Centers	AccessWire
11-Dec-2023	Reading Dental Associates Introduces New Solution for Sleep Apnea Patients	AccessWire
11-Dec-2023	HUMHEALTH - Chronic Care Management and Remote Patient Monitoring Software Leader	AccessWire
11-Dec-2023	Electra Therapeutics Appoints Kathy Dong, PharmD, MBA, as President and Chief Executive Officer	Businesswire
11-Dec-2023	Electra Therapeutics presents first clinical data from ongoing Phase 1b study of ELA026 for treatment of secondary hemophagocytic lymphohistiocytosis (sHLH)	Businesswire
11-Dec-2023	Merck Animal Health Receives Positive CVMP Opinion for an Injectable Formulation of BRAVECTO® (Fluralaner) for Use in Dogs	Businesswire
11-Dec-2023	Merck and Moderna Initiate INTerpath-002, a Phase 3 Study Evaluating V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) for Adjuvant Treatment of Patients with Certain Types of Resected Non-Small Cell Lung Cancer	Businesswire
11-Dec-2023	Cytovance Biologics and Alcami Unite to Deliver End-to-End Solutions for Biologics Developers	Businesswire
11-Dec-2023	Exosome Diagnostic Market worth $2.9 billion by 2030, growing at a CAGR of 29.4% – Exclusive Report by Allied Market Research	The Wire Times
11-Dec-2023	A Majority of Subjects in Jaguar Health's Placebo-Controlled Pivotal Phase 3 OnTarget Trial for Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Therapy Chose to Continue on to Stage II	AccessWire